The Archive · 32,142 records

Source documents — page 47 of 129

Source documents, page 47 of 129: records 11,501–11,750 of 32,142, titles F.

Browse by source, program, docket, document type or year.

Records 11,501–11,750 of 32,142

F

Florida Senate Commerce and Tourism Committee post-meeting packet, January 30, 2024Florida Senate Commerce and Tourism Committee post-meeting packet, January 30, 2024: SB…
Florida Senate Commerce and Tourism Committee post-meeting packet, March 20, 2023Florida Senate Commerce and Tourism Committee post-meeting packet, March 20, 2023: SB…
Florida Senate Commerce and Tourism Committee post-meeting packet, March 25, 2025Florida Senate Commerce and Tourism Committee post-meeting packet, March 25, 2025: SB 846…
Florida Woman Admits COVID-19 Relief Program FraudUSAO - New Jersey release, October 1, 2024: Jane Batista pleads guilty to wire fraud and…
Florida Woman Convicted for Conspiracy to Commit Mail FraudPress release: Cheryl Galloway is convicted of conspiracy to commit mail fraud in a…
Florida Woman Convicted of COVID-19 Relief FraudKeyaira Bostic convicted by a federal jury over an $84,515 PPP loan obtained with false…
Florida Woman Pleads Guilty to Conspiring to Prepare Fraudulent Loan Applications Totaling More Than $400,000Florida Woman Pleads Guilty to Conspiring to Prepare Fraudulent Loan Applications…
Florida Woman Pleads Guilty to Submitting Fraudulent EIDL and PPP Applications — USAO Colorado (March 31, 2022)Announcement of March 31, 2022 (USAO Colorado), No. 22-cr-00063-DDD: Patricia Gilroy…
Florida Woman Sentenced to 18 Months' Imprisonment for COVID-19 Relief Program Fraud (USAO New Jersey, 2026)DOJ release, April 20, 2026: Jane Batista gets 18 months for a scheme to obtain…
Florida Woman Sentenced to 19 Months for Fraudulent EIDL and PPP Applications in $865K Wire Fraud SchemeDOJ release, August 2, 2022: Patricia Gilroy of Naples sentenced to 19 months for EIDL…
Florida Woman Sentenced to Prison for Pandemic-Related FraudNorthern District of Georgia release, 2024-12-17: Calah Williams sentenced to three years…
Florida's State Plan for the American Rescue Plan Elementary and Secondary School Emergency Relief FundFlorida's ARP ESSER State Plan with an October 6, 2021 cover letter from Commissioner…
Florissant Woman Admits $100,000 Pandemic Loan FraudAnnouncement that Florissant woman Hobbs pleaded guilty to bank fraud and wire fraud over…
Florissant woman admits $828,000 pandemic loan and grant fraudFlorissant woman admits $828,813 pandemic loan and grant fraud, release dated July 11,…
Foire aux questions Prêt de secours pour préjudice économique (EIDL) lié à la COVID-19SBA COVID-19 EIDL frequently asked questions, in translation: what to submit, and why…
Follow the Money: Tackling Improper Payments — Rachel Greszler, Senior Research Fellow (March 31, 2022)Rachel Greszler of The Heritage Foundation testifies March 31, 2022 on improper payments:…
Follow the Money: Tackling Improper Payments, HearingArchived source document: Follow the Money: Tackling Improper Payments, Hearing.
Follow Up Letter - Apache Tribe of Oklahoma Use of Coronavirus Relief Fund PaymentFollow Up Letter - Apache Tribe of Oklahoma Use of Coronavirus Relief Fund Payment: PDF source…
Following Federal Court Order, Democrats Demand Trump Administration Restore MBDA Personnel & Grants it Unlawfully DismantledMay 28, 2025 release: Markey and Senate Democrats demand the administration restore MBDA…
following in order to satisfy the requirement to appear to represent the Texas Comptroller of Publicfollowing in order to satisfy the requirement to appear to represent the Texas Comptroller of……
Food Delivery Apps Strategize for Battles Ahead (Morning Consult)Morning Consult, April 01, 2021: DoorDash, Grubhub and Postmates expanded Washington…
Food delivery companies turn to K Street as industry scrutinizedArticle on food delivery companies hiring lobbyists in 2020 as the industry faces…
Food Hardship in the US During the Pandemic: What Can We Learn from Real-Time Data? (2022)Review of Income and Wealth article using Google Trends searches for foodbank to study…
Food Insecurity During the COVID-19 Pandemic: Evidence from a Survey of Low-Income Americans — Food SecurityFood Security paper (Fang, Thomsen, Nayga, Yang; published online 7 July 2021): a survey…
Food Safety and Inspection Service Pandemic Response at Establishments — Inspection Report 24801-0001-23USDA OIG Inspection Report 24801-0001-23, July 2022: FSIS pandemic response at meat and…
For Entry Of An Order (I) Authorizing AndFor Entry Of An Order (I) Authorizing And: source document dated June 10, 2024, lender materials…
For Filing - Benworth PR's Answer to FR Complaint 4915-5600-0567 1For Filing - Benworth PR's Answer to FR Complaint 4915-5600-0567 1: answer and Affirmative…
For Filing - Claudia Navarro's Answer to FR Complaint 4897-3108-4855 1For Filing - Claudia Navarro's Answer to FR Complaint 4897-3108-4855 1: answer and Affirmative…
for the caption, please file a motion to amend the captionfor the caption, please file a motion to amend the caption: source document dated October 28…
For the debtor listed above, a case has been filed under chapter 11 of the Bankruptcy Code. An order for relief has (dated 2019-09-13)Chapter 11 notice for Panthera Enterprises, LLC, No. 2:19-bk-00787 (Bankr. N.D.W. Va.),…
for the District of Delaware (the “Court”) entered the Order (I) Approving Bidding Procedures infor the District of Delaware (the “Court”) entered the Order (I) Approving Bidding Procedures in…
For the People Act of 2021 (Cong. Rec., April 26, 2021)Congressional Record, Senate, April 26, 2021, S2194: remarks on defense, Curtis T.…
For the reasons set forth in the Opinion filed yesterdayFor the reasons set forth in the Opinion filed yesterday: court filing dated September 14, 2021.…
For the reasons stated in the accompanying Memorandum Opinion, it is hereby ORDEREDOrder, December 15, 2025: Judge Stephanie A. Gallagher denies US Wind, Inc.’s motion for…
Forbes (Tax Notes), The 1973 Congressional Hearings That Reshaped Tax Privacy Protections (May 5, 2025)Archived source document: Forbes (Tax Notes), The 1973 Congressional Hearings That…
Foreclosure Fairness Account revenue reportWashington State Department of Commerce Foreclosure Fairness Account revenue report to…
Foreclosure Fairness Program 2022 legislative reportWashington Department of Commerce Foreclosure Fairness Program 2022 report under RCW…
Foreclosure Fairness Program Annual Report on Program Performance — Report to the Legislature (December 2020)Washington Foreclosure Fairness Program annual report to the Legislature, December 2020,…
Foreclosure Fairness Program Report to the Legislature — Washington State Department of CommerceReport — 2026 Fy25 Ffa Leg Report Final 95Db7E27 5056 4E13 B04A 53F8282Acfec.
foregoing Limited Objection and Reservation of Rights of Fischer U SA, Inc. to Debtors’ Motionforegoing Limited Objection and Reservation of Rights of Fischer U SA, Inc. to Debtors’ Motion…
foregoing Memorandum of Law in Support of Chapter 7 Trustee's Motion for An Orderforegoing Memorandum of Law in Support of Chapter 7 Trustee's Motion for An Order: amended…
Foreign National and Former Utah State University Student Club President Facing Federal Charges Relating to CARES Act COVID-19 FraudD. Utah press release, April 6, 2023: ex-student club president Mubarak Ukashat indicted…
Foreign-Owned Company To Pay Nearly $2 Million To Resolve Improper Paycheck Protection Program LoanEastern District of Michigan announcement, March 11, 2025: Monofrax LLC to pay $1,977,119…
Foreign-Owned Industrial Manufacturing Company to Pay $1.5 Million to Settle False Claims Act Allegations Related to Paycheck Protection Program LoanForeign-Owned Industrial Manufacturing Company to Pay $1.5 Million to Settle False Claims…
Forest Service's Response to the Coronavirus Pandemic at Recreation Sites — Inspection Report 08801-0001-22USDA OIG inspection 08801-0001-22 (May 2023): Forest Service COVID-19 measures at…
Forfeiture Verdict Form_11.1.2021Forfeiture Verdict Form_11.1.2021: source document dated May 27, 2020. Full text and citation…
Forge Global, "American Well IPO: Investment Opportunities & Pre-IPO Valuations"Forge Global page on the American Well IPO, updated Jul 15, 2025: legal notices on Forge…
Forgiveness Platform Lender Submission MetricsPPP forgiveness platform metrics as of July 30: 5,049,007 applications and…
Forgiveness Platform Lender Submission Metrics (Data as of October 23) — 2020 PPP Loan PopulationSource document — Forgiveness Platform Lender Submission Metrics (Data as of October 23)…
Forgiveness Platform Lender Submission Metrics, September 05Forgiveness Platform Lender Submission Metrics, September 05: report dated September 5, 2022. Full…
Form 10-K Annual Report for the fiscal year ended December 31, 2020 — Fifth Third Bancorp (Commission File Number 001-33653)Form 10-K Annual Report for the fiscal year ended December 31, 2020 — Fifth Third Bancorp…
Form 10-K Annual Report for the fiscal year ended December 31, 2020 — KeyCorp (Commission File Number 1-11302)Form 10-K Annual Report for the fiscal year ended December 31, 2020 — KeyCorp (Commission…
Form 10-K Annual Report for the fiscal year ended December 31, 2020 — Zions Bancorporation, National Association (Commission File Number 001-12307)Form 10-K Annual Report for the fiscal year ended December 31, 2020 — Zions…
Form 10-K Annual Report for the fiscal year ended December 31, 2021 — Elevate Credit, Inc. (Commission File Number 001-37680)Form 10-K Annual Report for the fiscal year ended December 31, 2021 — Elevate Credit,…
Form 10-K Annual Report for the fiscal year ended December 31, 2021 — Prosper Marketplace, Inc. and Prosper Funding LLCForm 10-K Annual Report for the fiscal year ended December 31, 2021 — Prosper…
Form 10-K Annual Report for the fiscal year ended December 31, 2023 — Ready Capital Corporation (Commission File Number 001-35808)Form 10-K Annual Report for the fiscal year ended December 31, 2023 — Ready Capital…
Form 10-K Annual Report for the fiscal year ended December 31, 2023 — Upstart Holdings, Inc. (Commission File Number 001-39797)Form 10-K Annual Report for the fiscal year ended December 31, 2023 — Upstart Holdings,…
Form 10-K Annual Report for the fiscal year ended December 31, 2024 — Ready Capital Corporation (Commission File Number 001-35808)Form 10-K Annual Report for the fiscal year ended December 31, 2024 — Ready Capital…
Form 10-K Annual Report for the fiscal year ended December 31, 2025 — LendingClub Corporation (Commission File Number 001-36771)Form 10-K Annual Report for the fiscal year ended December 31, 2025 — LendingClub…
Form 10-K Annual Report for the fiscal year ended December 31, 2025 — NewtekOne, Inc. (Commission File Number 814-01035)Form 10-K Annual Report for the fiscal year ended December 31, 2025 — NewtekOne, Inc.…
Form 10-K Annual Report for the fiscal year ended December 31, 2025 — Sezzle Inc. (Commission File Number 001-41781)Form 10-K Annual Report for the fiscal year ended December 31, 2025 — Sezzle Inc.…
Form 10-K Annual Report for the fiscal year ended July 31, 2024 — Intuit Inc. (Commission File Number 0-21180)Form 10-K Annual Report for the fiscal year ended July 31, 2024 — Intuit Inc. (Commission…
Form 10-K Annual Report for the fiscal year ended July 31, 2025 — Intuit Inc. (Commission File Number 0-21180)Form 10-K Annual Report for the fiscal year ended July 31, 2025 — Intuit Inc. (Commission…
Form 10-K Annual Report for the fiscal year ended June 30, 2026 — Affirm Holdings, Inc. (Commission File Number 001-39888)Form 10-K Annual Report for the fiscal year ended June 30, 2026 — Affirm Holdings, Inc.…
Form 10-K Annual Report — Zoom Video Communications, Inc., for the fiscal year ended January 31, 2021Zoom Video Communications Form 10-K for the fiscal year ended January 31, 2021: cover…
Form 10-K, Fiscal Year Ended December 31, 2012 — Avis Budget Group, Inc.Avis Budget Group, Inc. Form 10-K for the fiscal year ended December 31, 2012: 2012 total…
Form 10-K, Fiscal Year Ended December 31, 2019 — Diamond Eagle Acquisition Corp.Form 10-K, Fiscal Year Ended December 31, 2019 — Diamond Eagle Acquisition Corp.
Form 10-K, Fiscal Year Ended December 31, 2022 — Avis Budget Group, Inc.Avis Budget Group, Inc. Form 10-K for the fiscal year ended December 31, 2022: about $12…
Form 10-Q Quarterly Report for the quarterly period ended June 30, 2026 — Customers Bancorp, Inc. (Commission File Number 001-35542)Form 10-Q Quarterly Report for the quarterly period ended June 30, 2026 — Customers…
Form 10-Q Quarterly Report for the quarterly period ended March 31, 2023 — TraQiQ, Inc. (Commission File Number 000-56148)Form 10-Q Quarterly Report for the quarterly period ended March 31, 2023 — TraQiQ, Inc.…
Form 10-Q Quarterly Report for the quarterly period ended September 30, 2023 — BILL Holdings, Inc. (Commission File Number 001-39149)Form 10-Q Quarterly Report for the quarterly period ended September 30, 2023 — BILL…
Form 10-Q, Quarterly Period Ended March 31, 2021 — Avis Budget Group, Inc.Avis Budget Group, Inc. Form 10-Q for the quarter ended March 31, 2021: revenues of…
Form 4506-T (Rev. 3-2019), SVOG Request for Transcript of Tax ReturnSVOG version of IRS Form 4506-T (March 2019), Request for Transcript of Tax Return, with…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Barlow James F, transaction 06/18/2021Form 4 dated June 22, 2021 for Arcturus Therapeutics director BARLOW JAMES F: annual…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Barlow James F, transaction 06/22/2020Form 4 dated June 24, 2020 for Arcturus Therapeutics director BARLOW JAMES F: option to…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Barlow James F, transaction 06/23/2022Form 4 dated June 27, 2022 for Arcturus Therapeutics director BARLOW JAMES F: annual…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Chivukula Pad, 09/02/2021 signature dateForm 4 (September 2, 2021): Arcturus Therapeutics Chief Scientific Officer & COO sold…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Chivukula Pad, 10/04/2021 signature dateArcturus Therapeutics Form 4 (October 4, 2021): Chief Scientific Officer & COO sells…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Chivukula Pad, transaction 02/18/2020Form 4 for the Arcturus Therapeutics Chief Scientific Officer & COO (signed February 20,…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Chivukula Pad, transaction 06/21/2022Form 4 dated June 23, 2022 for the Arcturus Therapeutics Chief Scientific Officer & COO:…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Chivukula Pad, transaction 12/09/2022Form 4 dated December 13, 2022 for the Arcturus Therapeutics Chief Scientific Officer &…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Chivukula Pad, transaction 12/18/2020Arcturus Therapeutics Form 4 (December 22, 2020): Chief Scientific Officer & COO reports…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Farrell Peter C, transaction 06/18/2021Arcturus Therapeutics Form 4 (June 22, 2021): director FARRELL PETER C reports an annual…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Farrell Peter C, transaction 06/22/2020Arcturus Therapeutics Form 4 (June 24, 2020): director FARRELL PETER C reports a stock…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Farrell Peter C, transaction 06/23/2022Arcturus Therapeutics director FARRELL PETER C Form 4 (June 27, 2022): annual board…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Holmes Edward W, transaction 06/18/2021Arcturus Therapeutics director HOLMES EDWARD W Form 4 (June 22, 2021): annual board…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Holmes Edward W, transaction 06/22/2020Arcturus Therapeutics director HOLMES EDWARD W Form 4 (June 24, 2020): option on 15,000…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Holmes Edward W, transaction 06/23/2022Arcturus Therapeutics Form 4 (June 27, 2022): director HOLMES EDWARD W reports an annual…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Hughes Steven George, transaction 02/18/2020Form 4 signed February 20, 2020 by Arcturus Therapeutics Chief Development Officer Steven…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Hughes Steven George, transaction 12/18/2020Form 4 signed December 22, 2020 by Arcturus Therapeutics Chief Development Officer Steven…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Kummerfeld Keith C, transaction 02/18/2020Arcturus Therapeutics Form 4 (February 20, 2020) for its Vice President of Finance and…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Kummerfeld Keith C, transaction 06/12/2020Arcturus Therapeutics Form 4 (June 12, 2020): Vice President of Finance acquires 450…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Kummerfeld Keith C, transaction 06/21/2022Arcturus Therapeutics Form 4 (June 23, 2022): Vice President of Finance and Corporate…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Kummerfeld Keith C, transaction 12/09/2022Arcturus Therapeutics Form 4 (December 16, 2022): Vice President of Finance and Corporate…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Kummerfeld Keith C, transaction 12/18/2020Arcturus Therapeutics Form 4 (December 22, 2020): Vice President of Finance and Corporate…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Kurata Lance, transaction 06/21/2022Arcturus Therapeutics Form 4 (June 23, 2022): Chief Legal Officer Lance Kurata reports an…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Kurata Lance, transaction 12/09/2022Arcturus Therapeutics Form 4 (December 13, 2022): Chief Legal Officer reports an employee…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Kurata Lance, transaction 12/18/2020Arcturus Therapeutics Form 4 (December 22, 2020): Chief Legal Officer Lance Kurata…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Marantz Jing L., transaction 06/23/2022Arcturus Therapeutics Form 4 (June 27, 2022): director Jing L. Marantz reports an annual…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Markels John, transaction 12/08/2022Arcturus Therapeutics Form 4 (December 13, 2022): director Dr. John Markels reports…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Marquet Magda, transaction 06/18/2021Form 4 (June 22, 2021) for Arcturus Therapeutics director Marquet Magda: annual board…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Marquet Magda, transaction 06/22/2020Form 4 (June 24, 2020) for Arcturus Therapeutics director Marquet Magda: stock option for…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Marquet Magda, transaction 06/23/2022Form 4 (June 27, 2022) for Arcturus Therapeutics director Marquet Magda: annual board…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Marquet Magda, transaction 12/15/2022Arcturus Therapeutics Form 4 (December 19, 2022): director Marquet Magda reports 2,222…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Parschauer Karah Herdman, transaction 06/18/2021Arcturus Therapeutics Form 4 (June 22, 2021): director Parschauer Karah Herdman reports a…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Payne Joseph E, transaction 02/18/2020SEC Form 4 for Arcturus Therapeutics Holdings Inc. (February 20, 2020): stock option on…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Payne Joseph E, transaction 06/10/2020Form 4 (June 10, 2020): Arcturus Therapeutics President and CEO acquires 1,000 shares at…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Payne Joseph E, transaction 06/21/2022Arcturus Therapeutics Form 4 (June 23, 2022): President and CEO reports an employee stock…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Payne Joseph E, transaction 11/23/2022Form 4 (November 28, 2022): Arcturus Therapeutics President and CEO buys 5,000 shares at…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Payne Joseph E, transaction 12/09/2022Arcturus Therapeutics Form 4 (December 13, 2022): President and CEO reports an employee…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Payne Joseph E, transaction 12/18/2020Form 4 (December 22, 2020): Arcturus Therapeutics President and CEO reports a stock…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Sassine Andy, transaction 02/18/2020Arcturus Therapeutics Form 4 (February 20, 2020): stock option for 80,000 shares at…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Sassine Andy, transaction 06/10/2020Arcturus Therapeutics Form 4 (June 10, 2020): Chief Financial Officer acquires 5,000…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Sassine Andy, transaction 06/21/2022Form 4 (June 23, 2022): Arcturus Therapeutics Chief Financial Officer reports an employee…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Sassine Andy, transaction 08/15/2022Arcturus Therapeutics Form 4 (August 17, 2022): Chief Financial Officer buys 1,068 shares…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Sassine Andy, transaction 12/09/2022Form 4 (December 13, 2022): Arcturus Therapeutics Chief Financial Officer reports an…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Sassine Andy, transaction 12/18/2020Arcturus Therapeutics Form 4 (December 22, 2020): Chief Financial Officer reports a…
Form 4: Arcturus Therapeutics Holdings Inc. (ARCT), Ultragenyx Pharmaceutical Inc., transaction 05/20/2020Ultragenyx Pharmaceutical Inc. Form 4 for Arcturus Therapeutics (May 22, 2020): 600,000…
Form 4: Co-Diagnostics, Inc. (CODX), Benson Reed L, transaction 05/19/2021Form 4 for Co-Diagnostics, Inc. (CODX) General Counsel Reed L. Benson: options for…
Form 4: Co-Diagnostics, Inc. (CODX), Benson Reed L, transaction 05/24/2021Form 4 for Co-Diagnostics, Inc. (CODX) General Counsel Reed L. Benson: 4,584 restricted…
Form 4: Co-Diagnostics, Inc. (CODX), Benson Reed L, transaction 11/23/2020Co-Diagnostics, Inc. Form 4 signed November 24, 2020: CFO and Secretary Reed L. Benson…
Form 4: Co-Diagnostics, Inc. (CODX), Benson Reed L, transaction 11/25/2020Co-Diagnostics, Inc. Form 4 signed November 30, 2020: CFO Reed L. Benson exercises…
Form 4: Co-Diagnostics, Inc. (CODX), Brown Brian Lee, transaction 02/22/2021Form 4 for Co-Diagnostics, Inc. (CODX) Chief Financial Officer Brian L. Brown, signed…
Form 4: Co-Diagnostics, Inc. (CODX), Brown Brian Lee, transaction 05/23/2022Form 4 for Co-Diagnostics, Inc. (CODX) Chief Financial Officer Brian L. Brown: 21,666…
Form 4: Co-Diagnostics, Inc. (CODX), Brown Brian Lee, transaction 05/24/2021Form 4 for Co-Diagnostics, Inc. (CODX) Chief Financial Officer Brian L. Brown: 5,000…
Form 4: Co-Diagnostics, Inc. (CODX), Brown Brian Lee, transaction 06/06/2022Form 4 for Co-Diagnostics, Inc. (CODX) Chief Financial Officer Brian L. Brown: 225,000…
Form 4: Co-Diagnostics, Inc. (CODX), Brown Brian Lee, transaction 08/12/2021Form 4 for Co-Diagnostics, Inc. (CODX) Chief Financial Officer Brian L. Brown: grant of…
Form 4: Co-Diagnostics, Inc. (CODX), Brown Brian Lee, transaction 11/23/2021Form 4 for Co-Diagnostics, Inc. (CODX) Chief Financial Officer Brian L. Brown: 21,667…
Form 4: Co-Diagnostics, Inc. (CODX), Brown Brian Lee, transaction 11/23/2022Form 4 for Co-Diagnostics, Inc. (CODX) Chief Financial Officer Brian L. Brown: 59,167…
Form 4: Co-Diagnostics, Inc. (CODX), Durenard Eugene, transaction 01/07/2021Co-Diagnostics, Inc. Form 4 signed January 8, 2021: director Eugene Durenard reports a…
Form 4: Co-Diagnostics, Inc. (CODX), Durenard Eugene, transaction 01/08/2022Form 4 for Co-Diagnostics, Inc. (CODX) director Eugene Durenard: 12,500 restricted stock…
Form 4: Co-Diagnostics, Inc. (CODX), Durenard Eugene, transaction 01/13/2021Form 4 for Co-Diagnostics, Inc. (CODX) director Eugene Durenard, signed 01/15/2021: sale…
Form 4: Co-Diagnostics, Inc. (CODX), Durenard Eugene, transaction 05/20/2020; 05/22/2020 signatureCo-Diagnostics, Inc. Form 4 (May 22, 2020): director Eugene Durenard acquires shares…
Form 4: Co-Diagnostics, Inc. (CODX), Durenard Eugene, transaction 05/20/2020; 06/05/2020 signatureCo-Diagnostics, Inc. Form 4 signed June 5, 2020: director Eugene Durenard reports selling…
Form 4: Co-Diagnostics, Inc. (CODX), Durenard Eugene, transaction 06/25/2019Co-Diagnostics, Inc. Form 4 signed May 22, 2020: director Eugene Durenard reports option…
Form 4: Co-Diagnostics, Inc. (CODX), Durenard Eugene, transaction 07/11/2022Form 4 for Co-Diagnostics, Inc. (CODX) director Eugene Durenard: 70,000 restricted stock…
Form 4: Co-Diagnostics, Inc. (CODX), Durenard Eugene, transaction 09/08/2021Form 4 for Co-Diagnostics, Inc. (CODX) director Eugene Durenard: sale of 2,000 common…
Form 4: Co-Diagnostics, Inc. (CODX), Durenard Eugene, transaction 11/23/2020Co-Diagnostics, Inc. Form 4 signed November 24, 2020: director Eugene Durenard reports…
Form 4: Co-Diagnostics, Inc. (CODX), Durenard Eugene, transaction 11/23/2022Form 4 for Co-Diagnostics, Inc. (CODX) director Eugene Durenard: 11,667 units vested on…
Form 4: Co-Diagnostics, Inc. (CODX), Durenard Eugene, transaction 12/10/2020Co-Diagnostics, Inc. Form 4 signed December 14, 2020: director Eugene Durenard reports…
Form 4: Co-Diagnostics, Inc. (CODX), Egan Dwight H, transaction 01/15/2021Form 4 for Co-Diagnostics, Inc. (CODX) Chief Executive Officer Dwight H. Egan…
Form 4: Co-Diagnostics, Inc. (CODX), Egan Dwight H, transaction 05/23/2022Form 4 for Co-Diagnostics, Inc. (CODX) Chief Executive Officer Dwight H. Egan: 33,334…
Form 4: Co-Diagnostics, Inc. (CODX), Egan Dwight H, transaction 05/24/2021Form 4 for Co-Diagnostics, Inc. (CODX) director and Chief Executive Officer Dwight H.…
Form 4: Co-Diagnostics, Inc. (CODX), Egan Dwight H, transaction 06/06/2022Form 4 for Co-Diagnostics, Inc. (CODX) Chief Executive Officer Dwight H. Egan: grant of…
Form 4: Co-Diagnostics, Inc. (CODX), Egan Dwight H, transaction 08/12/2021Form 4 for Co-Diagnostics, Inc. (CODX) director and Chief Executive Officer Dwight H.…
Form 4: Co-Diagnostics, Inc. (CODX), Egan Dwight H, transaction 11/20/2020Co-Diagnostics, Inc. Form 4 signed November 25, 2020: Dwight H. Egan, Chief Executive…
Form 4: Co-Diagnostics, Inc. (CODX), Egan Dwight H, transaction 11/23/2021Form 4 for Co-Diagnostics, Inc. (CODX) Chief Executive Officer Dwight H. Egan: 33,333…
Form 4: Co-Diagnostics, Inc. (CODX), Egan Dwight H, transaction 11/23/2022Form 4 for Co-Diagnostics, Inc. (CODX) Chief Executive Officer Dwight H. Egan: 79,166…
Form 4: Co-Diagnostics, Inc. (CODX), Murphy Edward L., transaction 01/07/2021Form 4 for Co-Diagnostics, Inc. (CODX) director Edward L. Murphy, signed 01/08/2021:…
Form 4: Co-Diagnostics, Inc. (CODX), Murphy Ted, transaction 01/08/2022Form 4 for Co-Diagnostics, Inc. (CODX) director Edward L. Murphy: 12,500 units vested on…
Form 4: Co-Diagnostics, Inc. (CODX), Murphy Ted, transaction 07/11/2022Form 4 for Co-Diagnostics, Inc. (CODX) director Edward L. Murphy: award of 70,000…
Form 4: Co-Diagnostics, Inc. (CODX), Murphy Ted, transaction 11/23/2022Form 4 for Co-Diagnostics, Inc. (CODX) director Edward L. Murphy: 11,667 units vested…
Form 4: Co-Diagnostics, Inc. (CODX), Nelson James B, transaction 01/07/2021Form 4 for Co-Diagnostics, Inc. (CODX) director James B. Nelson, signed 01/08/2021: grant…
Form 4: Co-Diagnostics, Inc. (CODX), Nelson James B, transaction 01/08/2022Form 4 for Co-Diagnostics, Inc. (CODX) director James Nelson: annual vesting of 12,500…
Form 4: Co-Diagnostics, Inc. (CODX), Nelson James B, transaction 01/13/2021Form 4 for Co-Diagnostics, Inc. (CODX) director James B. Nelson, signed 01/15/2021: sales…
Form 4: Co-Diagnostics, Inc. (CODX), Nelson James B, transaction 07/11/2022Form 4 for Co-Diagnostics, Inc. (CODX) director James Nelson: 70,000 restricted stock…
Form 4: Co-Diagnostics, Inc. (CODX), Nelson James B, transaction 11/23/2022Form 4 for Co-Diagnostics, Inc. (CODX) director James Nelson: vesting of 11,667…
Form 4: Co-Diagnostics, Inc. (CODX), Satterfield Brent, transaction 02/23/2021"Exit" Form 4 for Co-Diagnostics, Inc. (CODX): Brent Satterfield no longer Chief Science…
Form 4: Co-Diagnostics, Inc. (CODX), Serbin Richard S, transaction 01/07/2021Form 4 for Co-Diagnostics, Inc. (CODX) director Richard S. Serbin, signed 01/08/2021:…
Form 4: Co-Diagnostics, Inc. (CODX), Serbin Richard S, transaction 01/08/2022Form 4 for Co-Diagnostics, Inc. (CODX) director Richard Serbin: 12,500 units vested…
Form 4: Co-Diagnostics, Inc. (CODX), Serbin Richard S, transaction 01/14/2021Form 4 for Co-Diagnostics, Inc. (CODX) director Richard S. Serbin, signed 01/15/2021:…
Form 4: Co-Diagnostics, Inc. (CODX), Serbin Richard S, transaction 02/10/2020Co-Diagnostics, Inc. Form 4 (June 5, 2020): director Richard S. Serbin reports a…
Form 4: Co-Diagnostics, Inc. (CODX), Serbin Richard S, transaction 05/19/2020; 05/21/2020 signatureCo-Diagnostics, Inc. Form 4 (May 21, 2020): director Richard S. Serbin acquires 25,000…
Form 4: Co-Diagnostics, Inc. (CODX), Serbin Richard S, transaction 05/19/2020; 06/05/2020 signatureCo-Diagnostics, Inc. Form 4 dated June 5, 2020: director Richard S. Serbin reports…
Form 4: Co-Diagnostics, Inc. (CODX), Serbin Richard S, transaction 05/28/2020Co-Diagnostics, Inc. Form 4 signed June 5, 2020: director Richard S. Serbin exercises an…
Form 4: Co-Diagnostics, Inc. (CODX), Serbin Richard S, transaction 07/11/2022Form 4 for Co-Diagnostics, Inc. (CODX) director Richard Serbin: 70,000 restricted stock…
Form 4: Co-Diagnostics, Inc. (CODX), Serbin Richard S, transaction 11/23/2020Co-Diagnostics, Inc. Form 4 dated November 24, 2020: director Richard S. Serbin reports…
Form 4: Co-Diagnostics, Inc. (CODX), Serbin Richard S, transaction 11/23/2022Form 4 for Co-Diagnostics, Inc. (CODX) director Richard Serbin: 11,667 units vested on…
Form 4: Co-Diagnostics, Inc. (CODX), Serbin Richard S, transaction 12/14/2020Co-Diagnostics, Inc. Form 4 signed December 15, 2020: director Richard Serbin reports…
Form 4: Cue Health Inc. (HLTH), Achar Christopher K, transaction 09/25/2023Form 4 for Cue Health Inc. director Chris Achar: 184,429 shares withheld at $0.45 for…
Form 4: Cue Health Inc. (HLTH), Achar Christopher K, transaction 12/05/2023Form 4 for Cue Health Inc. director Chris Achar: 7,465 shares withheld at $0.35 for taxes…
Form 4: Cue Health Inc. (HLTH), Javed Aasim, transaction 12/05/2023Form 4 for Cue Health Inc. Chief Financial Officer Aasim Javed: 11,623 shares withheld;…
Form 4: Cue Health Inc. (HLTH), Khattak Ayub K, transaction 09/25/2023Form 4 for Ayub Khattak, a Cue Health Inc. director and President: 31,938 shares withheld…
Form 4: Cue Health Inc. (HLTH), Khattak Ayub K, transaction 12/05/2023Form 4 for Ayub Khattak, a Cue Health Inc. director and President: 13,722 shares withheld…
Form 4: Cue Health Inc. (HLTH), Khattak Ayub K, transaction 12/26/2023Form 4 for Ayub Khattak, a Cue Health Inc. director and President: 31,938 shares withheld…
Form 4: Cue Health Inc. (HLTH), Palsis Erica, transaction 12/05/2023Form 4 for Cue Health Inc. General Counsel Erica Palsis: 6,272 shares withheld at $0.35…
Form 4: Cue Health Inc. (HLTH), Pollard Randall E., transaction 12/05/2023Form 4 for Cue Health Inc. Chief Accounting Officer Randall Pollard: 6,186 shares…
Form 4: Cue Health Inc. (HLTH), Sever Clint, transaction 09/25/2023Form 4 for Cue Health Inc. Chief Product Officer Clint Sever: 25,782 shares withheld at…
Form 4: Cue Health Inc. (HLTH), Sever Clint, transaction 12/05/2023Form 4 for Cue Health Inc. Chief Product Officer Clint Sever: 15,885 shares withheld at…
Form 4: Cue Health Inc. (HLTH), Sever Clint, transaction 12/26/2023Form 4 for Cue Health Inc. Chief Product Officer Clint Sever: 25,781 shares withheld at…
Form 4: CytoDyn Inc. (CYDY), Colachis Arian, transaction 09/30/2020Form 4 for CytoDyn Inc. (CYDY) officer Arian Colachis: 70,000 restricted stock units and…
Form 4: CytoDyn Inc. (CYDY), Colachis Arian, transaction 10/23/2020Form 4 for CytoDyn Inc. (CYDY) officer Arian Colachis: purchase of 10,000 shares at $2.5…
Form 4: CytoDyn Inc. (CYDY), Kelly Scott A., transaction 02/05/2021Form 4 for Kelly Scott A., CytoDyn Inc. (CYDY) director and officer: spouse's warrant…
Form 4: CytoDyn Inc. (CYDY), Kelly Scott A., transaction 03/31/2022Form 4 for Kelly Scott A., CytoDyn Inc. (CYDY) director and CMO: fully vested shares in…
Form 4: CytoDyn Inc. (CYDY), Kelly Scott A., transaction 06/15/2022CytoDyn Inc. (CYDY) Form 4 for Kelly Scott A.: 14,423 fully vested shares on 06/15/2022,…
Form 4: CytoDyn Inc. (CYDY), Kelly Scott A., transaction 06/30/2022CytoDyn Inc. (CYDY) director and CMO Kelly Scott A.: Form 4 for 13,736 fully vested…
Form 4: CytoDyn Inc. (CYDY), Kelly Scott A., transaction 07/15/2022Form 4 for Kelly Scott A., CytoDyn Inc. (CYDY) director and CMO: 13,112 fully vested…
Form 4: CytoDyn Inc. (CYDY), Kelly Scott A., transaction 07/31/2022Form 4 for Kelly Scott A., CytoDyn Inc. (CYDY) director and CMO: 7,492 fully vested…
Form 4: CytoDyn Inc. (CYDY), Kelly Scott A., transaction 08/06/2021Form 4 for Kelly Scott A., CytoDyn Inc. (CYDY) Chairman & CMO: 40,661 bonus shares and…
Form 4: CytoDyn Inc. (CYDY), Kelly Scott A., transaction 08/15/2022CytoDyn Inc. Form 4 for Kelly Scott A. (director, CMO): 6,950 common shares acquired…
Form 4: CytoDyn Inc. (CYDY), Kelly Scott A., transaction 08/28/2020Form 4 for Kelly Scott A., a CytoDyn Inc. (CYDY) director and officer: 74,800-share gift…
Form 4: CytoDyn Inc. (CYDY), Kelly Scott A., transaction 08/31/2022CytoDyn Inc. Form 4: Kelly Scott A. (director, CMO) acquired 11,094 common shares on…
Form 4: CytoDyn Inc. (CYDY), Kelly Scott A., transaction 09/15/2022CytoDyn Inc. Form 4: Kelly Scott A. (director, CMO) acquired 9,457 common shares on…
Form 4: CytoDyn Inc. (CYDY), Kelly Scott A., transaction 09/30/2020Form 4 for Kelly Scott A., CytoDyn Inc. (CYDY) director and officer: 250,000 units and a…
Form 4: CytoDyn Inc. (CYDY), Kelly Scott A., transaction 10/18/2021Form 4 for Kelly Scott A., CytoDyn Inc. (CYDY) Chairman & CMO: option on 1,750,000 shares…
Form 4: CytoDyn Inc. (CYDY), Migliarese Antonio, transaction 08/06/2021Form 4 for CytoDyn Inc. (CYDY) Chief Financial Officer Antonio Migliarese: 3,023 bonus…
Form 4: CytoDyn Inc. (CYDY), Mulholland Michael D., transaction 09/30/2020Form 4 for CytoDyn Inc. (CYDY) Chief Financial Officer Mulholland Michael D.: 100,000…
Form 4: CytoDyn Inc. (CYDY), Mulholland Michael D., transaction 12/22/2020Form 4 for CytoDyn Inc. (CYDY) Chief Financial Officer Michael D. Mulholland: four…
Form 4: CytoDyn Inc. (CYDY), Naydenov Jordan G, transaction 04/19/2021Form 4 for CytoDyn Inc. (CYDY) director Naydenov Jordan G: warrant for 250,000 shares…
Form 4: CytoDyn Inc. (CYDY), Naydenov Jordan G, transaction 09/23/2021Form 4 for CytoDyn Inc. (CYDY) director Naydenov Jordan G: warrant exercises for 888,888,…
Form 4: CytoDyn Inc. (CYDY), Naydenov Jordan G, transaction 10/23/2020Form 4 for CytoDyn Inc. (CYDY) director Naydenov Jordan G: purchase of 120,000 shares at…
Form 4: CytoDyn Inc. (CYDY), Naydenov Jordan G, transaction 11/02/2020Form 4 for CytoDyn Inc. (CYDY) director Naydenov Jordan G: 193,500 shares bought on…
Form 4: CytoDyn Inc. (CYDY), Patel Samir Rashmikant, transaction 06/25/2020Form 4 for CytoDyn Inc. (CYDY) director Patel Samir Rashmikant: 225,000-share option at…
Form 4: CytoDyn Inc. (CYDY), Pourhassan Nader, transaction 07/31/2020Form 4 for Pourhassan Nader, CytoDyn Inc. (CYDY) director and officer: 323,157 shares…
Form 4: CytoDyn Inc. (CYDY), Pourhassan Nader, transaction 08/06/2021CytoDyn Inc. (CYDY) Form 4 for Pourhassan Nader: 75,758 bonus shares and 200,000…
Form 4: CytoDyn Inc. (CYDY), Pourhassan Nader, transaction 09/30/2020Form 4 for Pourhassan Nader, CytoDyn Inc. (CYDY) director and officer: 500,000 units and…
Form 4: CytoDyn Inc. (CYDY), Rahman Mahboob U, transaction 10/16/2020Form 4 for CytoDyn Inc. (CYDY) Chief Scientific Officer Rahman Mahboob U: 200,000…
Form 4: CytoDyn Inc. (CYDY), Ray Nitya G., transaction 03/31/2022Form 4 for CytoDyn Inc. (CYDY) Chief Technology Officer Ray Nitya G.: fully vested shares…
Form 4: CytoDyn Inc. (CYDY), Ray Nitya G., transaction 06/15/2022Form 4 for Ray Nitya G., CytoDyn Inc. (CYDY) Chief Technology Officer: 13,671 fully…
Form 4: CytoDyn Inc. (CYDY), Ray Nitya G., transaction 06/30/2022CytoDyn Inc. (CYDY) Form 4: Chief Technology Officer Ray Nitya G. received 13,020 fully…
Form 4: CytoDyn Inc. (CYDY), Ray Nitya G., transaction 07/15/2022Form 4 for CytoDyn Inc. (CYDY) Chief Technology Officer Ray Nitya G.: 12,428 fully vested…
Form 4: CytoDyn Inc. (CYDY), Ray Nitya G., transaction 07/31/2022Form 4 for CytoDyn Inc. (CYDY) Chief Technology Officer Ray Nitya G.: 7,102 fully vested…
Form 4: CytoDyn Inc. (CYDY), Ray Nitya G., transaction 08/06/2021Form 4 for CytoDyn Inc. (CYDY) Chief Technology Officer Ray Nitya G.: bonus and…
Form 4: CytoDyn Inc. (CYDY), Ray Nitya G., transaction 08/15/2022CytoDyn Inc. Form 4: Chief Technology Officer Ray Nitya G. received 6,588 common shares…
Form 4: CytoDyn Inc. (CYDY), Ray Nitya G., transaction 08/31/2022CytoDyn Inc. Form 4, August 31, 2022: Ray Nitya G. (Chief Technology Officer) acquired…
Form 4: CytoDyn Inc. (CYDY), Ray Nitya G., transaction 09/15/2022CytoDyn Inc. Form 4, September 15, 2022: Chief Technology Officer Ray Nitya G. acquired…
Form 4: CytoDyn Inc. (CYDY), Ray Nitya G., transaction 09/30/2020Form 4 for CytoDyn Inc. (CYDY) Chief Technology Officer Ray Nitya G.: 200,000 units and a…
Form 4: CytoDyn Inc. (CYDY), Recknor Chris P, transaction 08/06/2021Form 4 for CytoDyn Inc. (CYDY) Chief Operating Officer Recknor Chris P: bonus shares and…
Form 4: CytoDyn Inc. (CYDY), Timmins Alan P, transaction 06/25/2020Form 4 for a CytoDyn Inc. (CYDY) director: option for 225,000 shares at $6.15 granted on…
Form 4: CytoDyn Inc. (CYDY), Welch David F, transaction 06/25/2020Form 4 for CytoDyn Inc. (CYDY) director Welch David F: non-qualified option on 225,000…
Form 4: CytoDyn Inc. (WAFD), Mulholland Michael D., transaction 12/17/2020Form 4 for CytoDyn Inc. Chief Financial Officer Michael D. Mulholland: option exercises…
Form 4: Emergent BioSolutions Inc. (EBS), Dayal Sujata Tyagi, transaction 07/21/2022Dayal Sujata Tyagi, a director of Emergent BioSolutions, received 11,852 restricted stock…
Form 4: Emergent BioSolutions Inc. (EBS), Fox Jennifer Lynne, transaction 03/01/2022Emergent BioSolutions Form 4: Fox Jennifer Lynne, EVP, Ext Aff, GC, Corp Sec, received…
Form 4: Emergent BioSolutions Inc. (EBS), Fox Jennifer Lynne, transaction 11/11/2022Emergent BioSolutions Form 4: 416 shares withheld from Fox Jennifer Lynne on 11/11/2022…
Form 4: Emergent BioSolutions Inc. (EBS), Fox Jennifer Lynne, transaction 12/09/2022Emergent BioSolutions Form 4: Fox Jennifer Lynne received 14,045 performance stock units…
Form 4: Emergent BioSolutions Inc. (EBS), Glessner Coleen, transaction 04/08/2022Glessner Coleen, Emergent BioSolutions EVP, Quality & Ethics, and CPL, received 5,913…
Form 4: Emergent BioSolutions Inc. (EBS), Glessner Coleen, transaction 12/09/2022Glessner Coleen, Emergent BioSolutions EVP, Quality & Ethics, and CPL, reports 24,078…
Form 4: Emergent BioSolutions Inc. (EBS), Harsanyi Zsolt, transaction 05/20/2021Harsanyi Zsolt, director of Emergent BioSolutions, reports 5,027 restricted stock units…
Form 4: Emergent BioSolutions Inc. (EBS), Harsanyi Zsolt, transaction 05/26/2022Emergent BioSolutions Form 4: director Harsanyi Zsolt acquired 8,446 restricted stock…
Form 4: Emergent BioSolutions Inc. (EBS), Hauer Jerome M, transaction 05/20/2021Emergent BioSolutions director Hauer Jerome M received 5,027 restricted stock units on…
Form 4: Emergent BioSolutions Inc. (EBS), Hauer Jerome M, transaction 05/26/2022Hauer Jerome M, an Emergent BioSolutions director, reports 8,446 restricted stock units…
Form 4: Emergent BioSolutions Inc. (EBS), Havey Adam, transaction 02/09/2021Emergent BioSolutions Inc. Form 4: Havey Adam (EVP, Business Operations) received 2,518…
Form 4: Emergent BioSolutions Inc. (EBS), Havey Adam, transaction 02/22/2022Havey Adam, Emergent BioSolutions EVP, Business Operations, reports 1,836 performance…
Form 4: Emergent BioSolutions Inc. (EBS), Havey Adam, transaction 02/23/2022Emergent BioSolutions Form 4: 424 and 828 shares withheld from Havey Adam on 02/23/2022…
Form 4: Emergent BioSolutions Inc. (EBS), Havey Adam, transaction 02/24/2021Havey Adam, EVP, Business Operations at Emergent BioSolutions, reports 3,744 restricted…
Form 4: Emergent BioSolutions Inc. (EBS), Havey Adam, transaction 02/28/2022Havey Adam, Emergent BioSolutions EVP, Business Operations, received 32,323 restricted…
Form 4: Emergent BioSolutions Inc. (EBS), Joulwan George A, transaction 05/20/2021Form 4: JOULWAN GEORGE A, a director of Emergent BioSolutions, acquired 5,027 restricted…
Form 4: Emergent BioSolutions Inc. (EBS), Joulwan George A, transaction 05/26/2022Emergent BioSolutions Form 4 for director JOULWAN GEORGE A: 8,446 restricted stock units…
Form 4: Emergent BioSolutions Inc. (EBS), Katkin Keith, transaction 04/02/2022Emergent BioSolutions director Katkin Keith received 8,595 restricted stock units on…
Form 4: Emergent BioSolutions Inc. (EBS), Kirk Sean, transaction 02/24/2021Kirk Sean, Emergent BioSolutions EVP, Manufacturing & Tech Ops, reports 3,209 restricted…
Form 4: Emergent BioSolutions Inc. (EBS), Kramer Robert, transaction 02/09/2021Emergent BioSolutions Inc. Form 4, February 9, 2021: Kramer Robert (President and CEO)…
Form 4: Emergent BioSolutions Inc. (EBS), Kramer Robert, transaction 02/22/2022Emergent BioSolutions President and CEO Kramer Robert reports 4,264 PSUs on 02/22/2022 as…
Form 4: Emergent BioSolutions Inc. (EBS), Kramer Robert, transaction 02/23/2022Kramer Robert, Emergent BioSolutions President and CEO, had 1,419 and 2,034 shares…
Form 4: Emergent BioSolutions Inc. (EBS), Kramer Robert, transaction 02/24/2021Emergent BioSolutions Form 4: President and CEO Kramer Robert received 14,975 restricted…
Form 4: Emergent BioSolutions Inc. (EBS), Kramer Robert, transaction 02/28/2022Emergent BioSolutions Form 4: Kramer Robert, President and CEO, received 33,833…
Form 4: Emergent BioSolutions Inc. (EBS), Kramer Robert, transaction 05/08/2021Emergent BioSolutions Form 4: 94 shares withheld at $61.62 from President and CEO Kramer…
Form 4: Emergent BioSolutions Inc. (EBS), Lindahl Richard S, transaction 02/09/2021Emergent BioSolutions Inc. Form 4, February 9, 2021: LINDAHL RICHARD S (EVP, Chief…
Form 4: Emergent BioSolutions Inc. (EBS), Lindahl Richard S, transaction 02/22/2022LINDAHL RICHARD S, Emergent BioSolutions EVP, Chief Financial Officer, reports 1,836 PSUs…
Form 4: Emergent BioSolutions Inc. (EBS), Lindahl Richard S, transaction 02/23/2022Form 4: Emergent BioSolutions withheld 516 and 983 shares from LINDAHL RICHARD S on…
Form 4: Emergent BioSolutions Inc. (EBS), Lindahl Richard S, transaction 02/24/2021Emergent BioSolutions Inc. Form 4, February 24, 2021: LINDAHL RICHARD S received 4,011…